Basel Medical Group Ltd
BMGL
$5.15
-$0.3421-6.23%
| Weiss Ratings | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 13.01% | |||
| 30-Day Total Return | 15.94% | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | 15.94% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -6.40% | |||
| 52-Week Low % Change | 37.28% | |||
| Price | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.50 | |||
| 52-Week Low Price | $3.75 | |||
| 52-Week Low Price (Date) | Mar 10, 2025 | |||
| 52-Week High Price (Date) | Apr 07, 2025 | |||
| Valuation | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 95.00M | |||
| Enterprise Value | 97.71M | |||
| Price/Earnings (TTM) | 54.36 | |||
| Earnings Per Share (TTM) | 0.09 | |||
| Earnings Per Share Growth | 16.91% | |||
| Price/Earnings To Growth | 3.21 | |||
| Price/Sales (TTM) | 11.20 | |||
| Price/Book (Q) | 15.00 | |||
| Enterprise Value/Revenue (TTM) | 13.08 | |||
| Price | $5.15 | |||
| Enterprise Value/EBITDA (TTM) | 60.76 | |||
| Enterprise Value/EBIT | 61.61 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 16.25M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 65 6291 9188 | |||
| Address | -- | |||
| Website | baselmedical.com | |||
| Country | Singapore | |||
| Year Founded | 2023 | |||
| Profitability | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 21.23% | |||
| Profit Margin | 20.57% | |||
| Management Effectiveness | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.47% | |||
| Return on Equity | 31.91% | |||
| Income Statement | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 7.46M | |||
| Total Revenue (TTM) | 7.47M | |||
| Revenue Per Share | $0.46 | |||
| Gross Profit (TTM) | 3.10M | |||
| EBITDA (TTM) | 1.61M | |||
| EBIT (TTM) | 1.59M | |||
| Net Income (TTM) | 1.54M | |||
| Net Income Avl. to Common (TTM) | 1.54M | |||
| Total Revenue Growth (Q YOY) | 4.71% | |||
| Earnings Growth (Q YOY) | -37.40% | |||
| EPS Diluted (TTM) | 0.09 | |||
| EPS Diluted Growth (Q YOY) | -37.27% | |||
| Balance Sheet | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.51M | |||
| Cash Per Share (Q) | $0.09 | |||
| Total Current Assets (Q) | 11.93M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.58M | |||
| Current Ratio (Q) | 2.258 | |||
| Book Value Per Share (Q) | $0.34 | |||
| Total Assets (Q) | 12.03M | |||
| Total Current Liabilities (Q) | 5.28M | |||
| Total Debt (Q) | 4.21M | |||
| Total Liabilities (Q) | 6.45M | |||
| Total Common Equity (Q) | 5.58M | |||
| Cash Flow | BMGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -5.80K | |||
| Cash from Financing (TTM) | -1.31M | |||
| Net Change in Cash (TTM) | 545.00K | |||
| Levered Free Cash Flow (TTM) | 1.62M | |||
| Cash from Operations (TTM) | 1.86M | |||
